Your browser doesn't support javascript.
loading
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.
Barazas, Marco; Gasparini, Alessia; Huang, Yike; Küçükosmanoglu, Asli; Annunziato, Stefano; Bouwman, Peter; Sol, Wendy; Kersbergen, Ariena; Proost, Natalie; de Korte-Grimmerink, Renske; van de Ven, Marieke; Jonkers, Jos; Borst, Gerben R; Rottenberg, Sven.
Affiliation
  • Barazas M; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Gasparini A; Division of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Huang Y; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Küçükosmanoglu A; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Annunziato S; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bouwman P; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Sol W; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Kersbergen A; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Proost N; Mouse Clinic for Cancer and Aging Research (MCCA), Preclinical Intervention Unit, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Korte-Grimmerink R; Mouse Clinic for Cancer and Aging Research (MCCA), Preclinical Intervention Unit, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van de Ven M; Mouse Clinic for Cancer and Aging Research (MCCA), Preclinical Intervention Unit, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Jonkers J; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands. sven.rottenberg@vetsuisse.unibe.ch j.jonkers@nki.nl g.borst@nki.nl.
  • Borst GR; Division of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands. sven.rottenberg@vetsuisse.unibe.ch j.jonkers@nki.nl g.borst@nki.nl.
  • Rottenberg S; Division of Molecular Pathology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands. sven.rottenberg@vetsuisse.unibe.ch j.jonkers@nki.nl g.borst@nki.nl.
Cancer Res ; 79(3): 452-460, 2019 02 01.
Article in En | MEDLINE | ID: mdl-30530501
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Proteins / Tumor Suppressor p53-Binding Protein 1 / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Proteins / Tumor Suppressor p53-Binding Protein 1 / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: United States